Nonoperating Income (Expense) in USD of Tengjun Biotechnology Corp. from Q3 2016 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Tengjun Biotechnology Corp. quarterly and annual Nonoperating Income (Expense) history and change rate from Q3 2016 to Q1 2023.
  • Tengjun Biotechnology Corp. Nonoperating Income (Expense) for the quarter ending 31 Mar 2023 was $7,419,012, a 107% increase year-over-year.
  • Tengjun Biotechnology Corp. annual Nonoperating Income (Expense) for 2022 was $124,350,261.
  • Tengjun Biotechnology Corp. annual Nonoperating Income (Expense) for 2021 was $738,234, a 10.7% increase from 2020.
  • Tengjun Biotechnology Corp. annual Nonoperating Income (Expense) for 2020 was $666,677.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

Tengjun Biotechnology Corp. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $7,419,012 +$3,830,700 +107% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q3 2022 $76,389,954 $29,329,707* +$29,222,157 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $47,167,797 $43,221,797* +$43,002,377 01 Apr 2022 30 Jun 2022 10-Q/A 16 Sep 2022 2022 Q2
Q1 2022 $4,165,420 $3,588,312 +$3,427,186 +2,127% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $738,234 $250,138 -$432,673 -63% 01 Oct 2021 31 Dec 2021 10-K 17 Apr 2023 2022 FY
Q3 2021 $1,170,907 $107,550 +$112,945 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $1,057,962 $219,420 +$224,720 01 Apr 2021 30 Jun 2021 10-Q/A 16 Sep 2022 2022 Q2
Q1 2021 $833,242 $161,126 +$166,565 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q1
Q4 2020 $666,677 $682,811 +$688,107 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $-21,430 $-5,395 -$170 -3.3% 01 Jul 2020 30 Sep 2020 10-Q 20 Oct 2021 2021 Q3
Q2 2020 $-21,260 $-5,300 -$173 -3.4% 01 Apr 2020 30 Jun 2020 10-Q 20 Jul 2021 2021 Q2
Q1 2020 $-21,087 $-5,439 -$715 -15% 01 Jan 2020 31 Mar 2020 10-Q 16 Apr 2021 2021 Q1
Q4 2019 $-20,372 $-5,296 -$567 -12% 01 Oct 2019 31 Dec 2019 10-K 17 Feb 2021 2020 FY
Q3 2019 $-19,805 $-5,225 -$588 -13% 01 Jul 2019 30 Sep 2019 10-Q 20 Oct 2020 2020 Q3
Q2 2019 $-19,217 $-5,127 -$656 -15% 01 Apr 2019 30 Jun 2019 10-Q 24 Jul 2020 2020 Q2
Q1 2019 $-18,561 $-4,724 -$653 -16% 01 Jan 2019 31 Mar 2019 10-Q 22 Apr 2020 2020 Q1
Q4 2018 $-17,908 $-4,729 01 Oct 2018 31 Dec 2018 10-K 28 Feb 2020 2019 FY
Q3 2018 $-4,637 -$660 -17% 01 Jul 2018 30 Sep 2018 10-Q 25 Oct 2019 2019 Q3
Q2 2018 $-4,471 -$590 -15% 01 Apr 2018 30 Jun 2018 10-Q 26 Jul 2019 2019 Q2
Q1 2018 $-4,071 01 Jan 2018 31 Mar 2018 10-Q 03 May 2019 2019 Q1
Q3 2017 $-3,977 -$343 -9.4% 01 Jul 2017 30 Sep 2017 10-Q 16 Oct 2018 2018 Q3
Q2 2017 $-3,881 01 Apr 2017 30 Jun 2017 10-Q 27 Jul 2018 2018 Q2
Q3 2016 $-3,634 01 Jul 2016 30 Sep 2016 10-Q 27 Oct 2017 2017 Q3

Tengjun Biotechnology Corp. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $124,350,261* +$123,612,027 01 Jan 2022 31 Dec 2022 10-K 17 Apr 2023 2022 FY
2021 $738,234 +$71,557 +11% 01 Jan 2021 31 Dec 2021 10-K 17 Apr 2023 2022 FY
2020 $666,677 +$687,049 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 $-20,372 -$2,464 -14% 01 Jan 2019 31 Dec 2019 10-K 17 Feb 2021 2020 FY
2018 $-17,908 -$2,163 -14% 01 Jan 2018 31 Dec 2018 10-K 28 Feb 2020 2019 FY
2017 $-15,745 +$8,096 +34% 01 Jan 2017 31 Dec 2017 10-K 08 Mar 2019 2018 FY
2016 $-23,841 01 Jan 2016 31 Dec 2016 10-K 07 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.